Amphastar Pharmaceuticals Inc., of Rancho Cucamonga, Calif., appointed Jack Y. Zhang president in addition to his roles as CEO, chief scientific officer and board member.
Cellectis SA, of Paris, appointed Carrie Brownstein chief medical officer.
Crown Bioscience Inc., of San Diego, appointed Jean-Pierre Wery executive chair of its board. He will also serve as chief technology officer for JSR Life Sciences LLC.
Five Prime Therapeutics Inc., of South San Francisco, appointed Thomas Civik president and CEO and to its board.
Immodulon Therapeutics Ltd., of Uxbridge, U.K., appointed Cellia K. Habita chief medical officer.
Summit Therapeutics plc, of Oxford U.K., appointed Robert Duggan CEO in addition to his role as chair of its board.
Tracon Pharmaceuticals Inc., of San Diego, appointed Shahe Garabedian senior vice president of quality assurance.